ClinicalTrials.Veeva

Menu

Effect of Acupressure on Pain, Anxiety and Vital Signs in Patients With Coronary Angiography

E

Eastern Mediterranean University

Status

Unknown

Conditions

Coronary Angiography
Vital Signs
Anxiety
Pain

Treatments

Behavioral: Acupressure

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The study was planned to determine the effect of acupressure on pain, anxiety and vital signs of patients with coronary angiography. Acupressure application was carried out by the responsible researcher, who is certified on this subject, by TRNC Dr. In the Cardiology Service of Burhan Nalbantoğlu Hospital, patients who have undergone angiography will be applied and measurements will be made before mobilization after their informed consent is obtained.

Full description

In this study, it is aimed to raise awareness for the use of painless, painless, economical, side-effect-free and easy-to-apply acupressure in nursing care in order to increase patient comfort by relieving pain and anxiety of patients during mandatory bed rest after coronary angiography. In addition, our study is important in terms of providing new information with a high level of evidence and providing a source for other studies on this subject.

Objective: The study was planned to determine the effect of acupressure on pain, anxiety and vital signs of patients with coronary angiography.

Hypothesis 1 H0: There is no difference in Visual Analog Scale mean scores between the acupressure group, the sham (pseudo-acupressure) group, and the control group.

H1: There is a difference in Visual Analog Scale mean scores between the acupressure group, the sham (pseudo-acupressure) group, and the control group.

Hypothesis 2 H0: There is no difference between the Spielberger State Anxiety Inventory mean scores between the acupressure group, the sham (pseudo-acupressure) group, and the control group.

H1: There is a difference between the Spielberger State Anxiety Inventory mean scores between the acupressure group, the sham (pseudo-acupressure) group, and the control group.

Hypothesis 3 H0: There is no difference in Systolic Blood Pressure between the acupressure group, the sham (false acupressure) group and the control group.

H1: There is a difference in Systolic Blood Pressure between the acupressure group, the sham (false acupressure) group and the control group.

Hypothesis 4 H0: There is no difference in Diastolic Blood Pressure between the acupressure group, the sham (false acupressure) group and the control group.

H1: There is a difference in Diastolic Blood Pressure between the acupressure group, the sham (false acupressure) group and the control group.

Hypothesis 5 H0: There is no difference in Heart Rate between the acupressure group, the sham (false acupressure) group and the control group.

H1: There is a difference between the acupressure group, the sham (false acupressure) group and the control group in terms of Heart Rate.

Hypothesis 6 H0: There is no difference in Respiration Rate between the acupressure group, the sham (false acupressure) group and the control group.

H1: There is a difference between the acupressure group, the sham (false acupressure) group and the control group in terms of Respiration Rate.

Hypothesis 7 H0: There is no difference in Cortisol Level between the acupressure group, the sham (false acupressure) group and the control group.

H1: There is a difference between the acupressure group, the sham (false acupressure) group and the control group in terms of Cortisol Level.

"Personal Information Form, "Spielberger State Anxiety Scale", "Visual Analogue Scale" and "Vital Signs Follow-up Form" will be administered to all patients (acupressure, sham acupressure and control groups) included in the study (1. "Spielberger State Anxiety Inventory", "After the measurement, half an hour after applying acupressure to the points determined for both groups (2nd measurement), two hours later (3rd measurement) and just before mobilization (4th measurement)," "Visual Analogue Scale" and "Vital Signs Follow-up Form" will be applied again.

It was created by the researcher to track the cortisol level. It is designed to include a total of 2 measurements (pre/post acupressure).

Enrollment

105 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • First time coronary angiography performed
  • Coronary angiography performed from the femoral region,
  • over the age of 18,
  • Willing to participate in the research,
  • Able to understand and speak Turkish,
  • Open to communication,
  • Planned (non-urgent) coronary angiography
  • No complications after angiography
  • Stent etc. during angiography. no other attempt has been made
  • No deformity or lesion in the areas where acupressure will be applied
  • Not taking sedatives or pain relievers 5 hours before the angiography procedure,
  • No acupressure experience
  • Not diagnosed with anxiety disorder and not receiving medical treatment
  • Not diagnosed with depression and not receiving medical treatment
  • No chronic pain
  • Patients without mental illness.

Exclusion criteria

    • Previous coronary angiography
  • Coronary angiography from the femoral region is not performed,
  • under the age of 18,
  • pregnant,
  • Those who do not agree to participate in the research,
  • Can't understand or speak Turkish,
  • Unable to communicate
  • Unplanned (urgent) Coronary angiography Patients
  • Any complications after angiography
  • Stent etc. during angiography. another attempt has been made
  • Any deformity or lesion in the areas where acupressure will be applied,
  • Those who took sedatives or painkillers 5 hours before the angiography procedure,
  • Experience with acupressure
  • Anxiety disorder and receiving treatment,
  • Diagnosed with depression and receiving treatment,
  • Having chronic pain,
  • Patients with mental disorders.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

105 participants in 3 patient groups, including a placebo group

Acupressure Group
Experimental group
Description:
Applicable to the acupressure group; Heart meridian 7th point (HT7), large intestine meridian 4th point (LI4) and pericardium 6th point (PC6), a total of three points will be applied. Afterwards, sequential (breathing rhythm) compressions will be applied to the determined acupressure points by the researcher without lifting the finger, taking into account the pain threshold of the individual who is applied with the thumb, with 10 seconds of pressure for two seconds of relief. Since the symmetry of the selected three different points on the other extremity will also be applied, a total of 12 minutes of compression will be applied to each point, provided that it is two minutes. Depending on the preparation and compression time on each point, the session duration of each patient will be approximately 16 minutes.
Treatment:
Behavioral: Acupressure
Sham Group
Placebo Comparator group
Description:
n the acupressure application to the Sham group, pressure will be exerted on the bone region where the meridians do not pass, parallel to the HT7, LI4, PC6 and points (approximately 1-1.5 cm away) (Figure 4). Before the application, the acupressure points will be heated for about 20 seconds and the tissue sensitivity will be reduced by rubbing and they will be made ready for the acupressure application. Afterwards, the acupressure points determined will be pressed with the thumb by the researcher with a lower intensity than the normal application pressure for two minutes. Similar to the acupressure group, the sham group will be applied to symmetrical points. In this direction, a session will last 16 minutes for each patient, as in the acupressure group, together with the duration of the pre-procedure preparation and applications.
Treatment:
Behavioral: Acupressure
Control Group
No Intervention group
Description:
Patients in the control group will not receive any intervention.

Trial contacts and locations

1

Loading...

Central trial contact

SELDA BAL, 1

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems